Now, Cannabotech, an Israeli biomedical firm that innovates botanical-based solutions for oncology and preventive medicine, has found promising results in an experiment involving its Integrative-Colon product, based on a press release. The formula combines mushroom extracts together with cannabinoids from the cannabis plant, then tested on various subtypes of colon cancer. They found that the ingredients of the formulation acted more effectively compared to isolating the cannabinoids, and that the active ingredients showed great synergy working together. Based on the findings, the Integrative-Colon product was able to kill more than 90% of colon cancer cells
Low-dose THC beverages typically contain somewhere between 2 and 5 mg of THC per serving.…
A few dozen strangers answered one question, and here's what they told me. Cannabis rarely…
Federal officials admitted under oath at the DEA marijuana rescheduling hearing that the 54-year-old test…
Discover why Donald Trump lost the 2026 midterms, how the hemp and cannabis industries survived…
On October 29, Fox News ran a column by Dr. Marc Siegel, the network’s senior medical…
Is cannabis a miracle cure or a gateway to ruin? We break down the latest…